NCT04773574

Brief Summary

The prevalence of myopia is seemingly increasing, and it is one of the major causes of blindness. High myopia is defined as a refractive error with spherical equivalent exceeding -6 diopters and/or the axial length longer than 26.5 mm. The global prevalence of high myopia is estimated to rise from 2.7% of the world population in 2010 to 9.8% of the world population in 2050. High myopia is characterized by axial length elongation, and consequent stretching of the posterior eye wall (thin retina and choroid). There are many complications of high myopia such as posterior staphyloma, lacquer cracks and myopic choroidal neovascularization. Normal labour may cause the ocular complication in pregnant women with high myopia, such as macular hemorrhage. Therefore, the caesarean section with epidural anesthesia is recommended. Moreover, there is no standard screening guideline for pregnant women with high myopia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2021

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 26, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

June 30, 2021

Status Verified

June 1, 2021

Enrollment Period

3.5 years

First QC Date

February 25, 2021

Last Update Submit

June 29, 2021

Conditions

Keywords

high myopiapregnancychoroidal thicknessretinal vascular densityretinal nerve fiber layer thicknesscorneal curvature

Outcome Measures

Primary Outcomes (1)

  • Choroidal thickness

    Choroidal thickness was measured by optical coherence tomography

    40 weeks

Secondary Outcomes (4)

  • Retinal vascular density

    40 weeks

  • Retinal nerve fiber layer thickness

    40 weeks

  • Corneal thickness

    40 weeks

  • Corneal curvature

    40 weeks

Study Arms (1)

Normal pregnant women with high myopia

EXPERIMENTAL

Corneal topography, Optical coherence tomography (OCT) and Optical coherence tomography angiography (OCTA) were performed in each trimesters and at 6 weeks after childbirth.

Device: Corneal topography, Optical coherence tomography (OCT) and Optical coherence tomography angiography (OCTA)

Interventions

Ocular investigations were performed in each trimesters and at 6 weeks after childbirth. 1. st trimester : gestational age 8-12 weeks 2. nd trimester : gestational age 24-28 weeks 3. rd trimester : gestational age 34-38 weeks

Normal pregnant women with high myopia

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \> 18 years
  • high myopia: spherical equivalent \> 6 diopters and/or axial length \> 26.5 mm
  • singleton pregnancy
  • clear ocular media
  • written inform consent

You may not qualify if:

  • high risk pregnancy such as pre-eclampsia, gestational diabetes mellitus, hyperthyroidism and asthma.
  • history of retinal diseases such as macular edema and retinal vascular occlusion
  • history of intraocular inflammation or endophthalmitis
  • history of intraocular laser treatment
  • history of intraocular surgery
  • Withdrawal criteria
  • childbirth before 34 weeks' gestation
  • multifetal pregnancy was detected by ultrasound
  • high risk pregnancy which could not follow the research protocol such as severe pre-eclampsia
  • retinal diseases occur during the follow-up period such as central serous chorioretinopathy, retinal detachment and choroidal neovascularization
  • significant ocular trauma during the follow-up period
  • severe peripartum or postpartum complications such as thromboembolic disease and postpartum hemorrhage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Corneal TopographyTomography, Optical Coherence

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosisTomography, OpticalOptical ImagingDiagnostic ImagingTomographyInvestigative Techniques

Study Officials

  • Suthasinee Sinawat, MD

    KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Suthasinee S, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 25, 2021

First Posted

February 26, 2021

Study Start

July 1, 2021

Primary Completion

December 30, 2024

Study Completion

June 30, 2025

Last Updated

June 30, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share